Aspira Pathlab & Diagnostics Limited
BSE: ASPIRA.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Pankaj Jashwant Shah
- Employees
- 115
- Headquarters
- Navi Mumbai, India
- IPO year
- 2024
- Market cap
- ₹657.7M
- Website
- http://www.aspiradiagnostics.com
Loading ASPIRA…
Loading profile data…Frequently asked questions about ASPIRA
What does Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) do?
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The firm involves in the pathological investigations of bio-chemistry, hematology, histopathology, microbiology, immune-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its services includes on-site...
Where does ASPIRA.BO trade?
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) trades on the Bombay Stock Exchange.
What sector is ASPIRA.BO in?
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Aspira Pathlab & Diagnostics Limited?
Pankaj Jashwant Shah is the chief executive officer of Aspira Pathlab & Diagnostics Limited (ASPIRA.BO).
Where is Aspira Pathlab & Diagnostics Limited headquartered?
Aspira Pathlab & Diagnostics Limited is headquartered in India.
Does ASPIRA.BO pay a dividend?
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ASPIRA.BO go public?
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) completed its initial public offering in 2024.